Sabra Health Care REIT, Inc. (SBRA)

Sabra Health Care REIT Stock Forecast

Stock Price Forecast

The 8 analysts that cover Sabra Health Care REIT stock have a consensus rating of "Buy" and an average price target of $22, which forecasts a 9.51% increase in the stock price over the next year. The lowest target is $21 and the highest is $24.

Price Target: $22 (+9.51%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$21	$22	$22	$24
Change	+4.53%	+9.51%	+9.51%	+19.46%

* Price targets were last updated on Mar 26, 2026.

Analyst Ratings

The average analyst rating for Sabra Health Care REIT stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Nov '25	Dec '25	Jan '26	Feb '26	Mar '26	Apr '26
Strong Buy	0	0	0	1	1	1
Buy	3	3	3	3	2	2
Hold	6	6	5	5	5	5
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	9	9	8	9	8	8

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
John Kilichowski Wells Fargo	Wells Fargo	Buy Maintains $21 → $22	Buy	Maintains	$21 → $22	+9.51%	Mar 26, 2026
Michael Lewis Truist Securities	Truist Securities	Hold Maintains $21 → $22	Hold	Maintains	$21 → $22	+9.51%	Mar 13, 2026
Nicholas Yulico Scotiabank	Scotiabank	Hold Maintains $20 → $21	Hold	Maintains	$20 → $21	+4.53%	Mar 2, 2026
Michael Goldsmith UBS	UBS	Hold Maintains $20 → $21	Hold	Maintains	$20 → $21	+4.53%	Feb 19, 2026
Nick Joseph Citigroup	Citigroup	Strong Buy Maintains $21 → $24	Strong Buy	Maintains	$21 → $24	+19.46%	Feb 18, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

833.97M

Increased by 7.50%

from 775.76M

Revenue Next Year

909.64M

Increased by 9.07%

from 833.97M

EPS This Year

0.74

Increased by 15.21%

from 0.64

EPS Next Year

0.79

Increased by 6.80%

from 0.74

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	388.24M	531.95M	644.62M	702.64M	775.76M	833.97M	909.64M
Revenue Growth	-35.38%	37.02%	21.18%	9.00%	10.41%	7.50%	9.07%
EPS	-0.52	-0.34	0.06	0.54	0.64	0.74	0.79
EPS Growth	-	-	-	807.61%	18.52%	15.21%	6.80%
Forward PE	-	-	-	-	-	27.25	25.51
No. Analysts	-	-	-	-	-	10	8

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027	2028	2029	2030	2031
High	960.4M	1.1B
Avg	834.0M	909.6M
Low	721.7M	770.7M

Revenue Growth

Revenue Growth	2026	2027	2028	2029	2030	2031
High	23.8%	28.4%
Avg	7.5%	9.1%
Low	-7.0%	-7.6%

EPS Forecast

EPS	2026	2027	2028
High	0.88	0.86
Avg	0.74	0.79
Low	0.65	0.74

EPS Growth

EPS Growth	2026	2027	2028
High	37.8%	16.8%
Avg	15.2%	6.8%
Low	1.1%	-0.3%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.